Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes

Atherosclerosis

Volumn 192, Issue 1, 2007, Pages 204-210

  Qi, Lu ^a,b   Liu, Simin ^c   Rifai, Nader ^d   Hunter, David ^a,b   Hu, Frank B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Apolipoprotein; Diabetic patients; Gene cluster; HDL cholesterol; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; NURSES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 34247104590     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.006     Document Type: Article

References (28)

1. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
2. Szapary P.O., and Rader D.J. The triglyceride-high-density lipoprotein axis: an important target of therapy?. Am Heart J 148 (2004) 211-221
3. Friedlander Y., Kark J.D., and Stein Y. Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic. Hum Hered 36 (1986) 143-153
4. Wang Q.F., Liu X., O'Connell J., et al. Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum Mol Genet 13 (2004) 1049-1056
5. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11 (2002) 3039-3046
6. Shoulders C.C., Harry P.J., Lagrost L., et al. Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 87 (1991) 239-247
7. Ginsberg H.N., Le N.A., Goldberg I.J., et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78 (1986) 1287-1295
8. Pennacchio L.A., and Rubin E.M. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol 23 (2003) 529-534
9. Shioji K., Mannami T., Kokubo Y., et al. An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese. J Hum Genet 49 (2004) 433-439
10. Ordovas J.M., Corella D., Cupples L.A., et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 75 (2002) 38-46
11. Xu C.F., Talmud P., Schuster H., et al. Association between genetic variation at the APO AI-CIII-AIV gene cluster and familial combined hyperlipidemia. Clin Genet 46 (1994) 385-397
12. Dammerman M., Sandkuijl L.A., Halaas J.L., Chung W., and Breslow J.L. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90 (1993) 4562-4566
13. Pennacchio L.A., Olivier M., Hubacek J.A., et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11 (2002) 3031-3038
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
15. Tregouet D.A., Escolano S., Tiret L., Mallet A., and Golmard J.L. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68 (2004) 165-177
16. Olivier M., Wang X., Cole R., et al. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 83 (2004) 912-923
17. Lai C.Q., Demissie S., Cupples L.A., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45 (2004) 2096-2105
18. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294 (2001) 169-173
19. Schaap F.G., Rensen P.C., Voshol P.J., et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279 (2004) 27941-27947
20. Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase. J Biol Chem 280 22 (2005) 21553-21560
21. O'Brien P.J., Alborn W.E., Sloan J.H., et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 51 (2005) 351-359
22. Lai C.Q., Parnell L.D., and Ordovas J.M. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol 16 (2005) 153-166
23. Olivieri O., Bassi A., Stranieri C., et al. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 44 (2003) 2374-2381
24. Baroukh N., Bauge E., Akiyama J., et al. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice. Arterioscler Thromb Vasc Biol 24 (2004) 1297-1302
25. Utermann G., and Beisiegel U. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 99 (1979) 333-343
26. Lohse P., Kindt M.R., Rader D.J., and Brewer Jr. H.B. Three genetic variants of human plasma apolipoprotein A-IV. apoA-IV-1(Thr347-Ser), apoA-IV-0(Lys167-Glu, ln360-His), and apoA-IV-3(Glu165-Lys). J Biol Chem 266 (1991) 13513-13518
27. von Eckardstein A., Funke H., Schulte M., et al. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 50 (1992) 1115-1128
28. Wong W.M., Hawe E., Li L.K., et al. Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels. Circ Res 92 (2003) 969-975